The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants

Michal Ariela Raz; Jon Arnason; Osnat Bairey; Lev Shvidel; Ariel Aviv; Sharon Ben Baruch; Chava Perry; Nadav Sarid; Ilya Kirgner; Varon Dvid; Yair Herishanu; Irit Avivi

doi:10.1111/bjh.16422

The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants

Michal Ariela Raz, Jon Arnason, Osnat Bairey, Lev Shvidel, Ariel Aviv, Sharon Ben Baruch, Chava Perry, Nadav Sarid, Ilya Kirgner, Varon Dvid, Yair Herishanu, Irit Avivi^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	e31-e33
Journal	British Journal of Haematology
Volume	189
Issue number	2
DOIs	https://doi.org/10.1111/bjh.16422
State	Published - 1 Apr 2020

Keywords

bleeding risk
direct oral anticoagulants
ibrutinib

Access to Document

10.1111/bjh.16422

Cite this

@article{04bc76fe05934f519cdd5dee9e8b9c94,

title = "The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants",

keywords = "bleeding risk, direct oral anticoagulants, ibrutinib",

author = "Raz, {Michal Ariela} and Jon Arnason and Osnat Bairey and Lev Shvidel and Ariel Aviv and {Ben Baruch}, Sharon and Chava Perry and Nadav Sarid and Ilya Kirgner and Varon Dvid and Yair Herishanu and Irit Avivi",

year = "2020",

month = apr,

day = "1",

doi = "10.1111/bjh.16422",

language = "אנגלית",

volume = "189",

pages = "e31--e33",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants

AU - Raz, Michal Ariela

AU - Arnason, Jon

AU - Bairey, Osnat

AU - Shvidel, Lev

AU - Aviv, Ariel

AU - Ben Baruch, Sharon

AU - Perry, Chava

AU - Sarid, Nadav

AU - Kirgner, Ilya

AU - Dvid, Varon

AU - Herishanu, Yair

AU - Avivi, Irit

PY - 2020/4/1

Y1 - 2020/4/1

KW - bleeding risk

KW - direct oral anticoagulants

KW - ibrutinib

UR - http://www.scopus.com/inward/record.url?scp=85081220278&partnerID=8YFLogxK

U2 - 10.1111/bjh.16422

DO - 10.1111/bjh.16422

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32150642

AN - SCOPUS:85081220278

SN - 0007-1048

VL - 189

SP - e31-e33

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -

The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants

Keywords

Access to Document

Other files and links

Cite this